Alteration in PNMA1 expression is associated with poor prognosis and tumor immune infiltration in head and neck squamous cell carcinoma

Background: A significant percentage of the world is distressed due to the widespread and aggressive head and neck squamous cell carcinoma (HNSCC). The prognosis for people with HNSCC remains grim, despite progress in treatment techniques. This underscores the pressing demand for the discovery of no...

Full description

Saved in:
Bibliographic Details
Main Authors: Dakshitha Sankar, Balachander Kannan, Vijayashree Priyadharsini Jayaseelan, Jeevitha Manicka Vasagam, Paramasivam Arumugam
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Journal of Oral Biology and Craniofacial Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2212426823001343
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846159448780832768
author Dakshitha Sankar
Balachander Kannan
Vijayashree Priyadharsini Jayaseelan
Jeevitha Manicka Vasagam
Paramasivam Arumugam
author_facet Dakshitha Sankar
Balachander Kannan
Vijayashree Priyadharsini Jayaseelan
Jeevitha Manicka Vasagam
Paramasivam Arumugam
author_sort Dakshitha Sankar
collection DOAJ
description Background: A significant percentage of the world is distressed due to the widespread and aggressive head and neck squamous cell carcinoma (HNSCC). The prognosis for people with HNSCC remains grim, despite progress in treatment techniques. This underscores the pressing demand for the discovery of novel biomarkers to enable early detection and improve prognostic categorization. Objective: The present study aims to identify the expression of the PNMA1 gene in HNSCC with clinicopathological characteristics, prognosis, and association of immune cells infiltration. Methods: The TCGA-HNSCC dataset first evaluated PNMA1 expression and its relationship to clinical aspects of HNSCC. Following that, oral squamous cell carcinoma (OSCC), a primary HNSCC type, is used to validate PNMA1 mRNA expression, via quantitative reverse transcription PCR (RT-qPCR). The Kaplan-Meier plot was used to assess survival rates, and the Tumour Immune Estimation Resource (TIMER) database was used to examine the relationship between PNMA1 and immune cells infiltration. Results: The expression of PNMA1 significantly increased in HNSCC and OSCC tumors. Significant correlations have been found between the increased PNMA1 expression and clinicopathological characteristics of HNSCC, such as tumor stage, grade, metastasis, HPV status and patient survival. PNMA1 expression also correlated with immune cell infiltration and immune regulator genes. Conclusion: In conclusion, the present study demonstrated that the PNMA1 expression significantly increased in HNSCC and was associated with HNSCC patient's prognosis. Hence, PNMA1 could serve as a novel prognostic biomarker and a promising therapeutic target for HNSCC.
format Article
id doaj-art-337b292510a7411eb41dcd3571c7001f
institution Kabale University
issn 2212-4268
language English
publishDate 2024-01-01
publisher Elsevier
record_format Article
series Journal of Oral Biology and Craniofacial Research
spelling doaj-art-337b292510a7411eb41dcd3571c7001f2024-11-23T06:30:31ZengElsevierJournal of Oral Biology and Craniofacial Research2212-42682024-01-0114117Alteration in PNMA1 expression is associated with poor prognosis and tumor immune infiltration in head and neck squamous cell carcinomaDakshitha Sankar0Balachander Kannan1Vijayashree Priyadharsini Jayaseelan2Jeevitha Manicka Vasagam3Paramasivam Arumugam4Department of Periodontics, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, IndiaCentre for Cellular and Molecular Research, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, IndiaCentre for Cellular and Molecular Research, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, IndiaDepartment of Periodontics, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, IndiaCentre for Cellular and Molecular Research, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, India; Corresponding author. Centre for Cellular and Molecular Research, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, 600077, TN, India.Background: A significant percentage of the world is distressed due to the widespread and aggressive head and neck squamous cell carcinoma (HNSCC). The prognosis for people with HNSCC remains grim, despite progress in treatment techniques. This underscores the pressing demand for the discovery of novel biomarkers to enable early detection and improve prognostic categorization. Objective: The present study aims to identify the expression of the PNMA1 gene in HNSCC with clinicopathological characteristics, prognosis, and association of immune cells infiltration. Methods: The TCGA-HNSCC dataset first evaluated PNMA1 expression and its relationship to clinical aspects of HNSCC. Following that, oral squamous cell carcinoma (OSCC), a primary HNSCC type, is used to validate PNMA1 mRNA expression, via quantitative reverse transcription PCR (RT-qPCR). The Kaplan-Meier plot was used to assess survival rates, and the Tumour Immune Estimation Resource (TIMER) database was used to examine the relationship between PNMA1 and immune cells infiltration. Results: The expression of PNMA1 significantly increased in HNSCC and OSCC tumors. Significant correlations have been found between the increased PNMA1 expression and clinicopathological characteristics of HNSCC, such as tumor stage, grade, metastasis, HPV status and patient survival. PNMA1 expression also correlated with immune cell infiltration and immune regulator genes. Conclusion: In conclusion, the present study demonstrated that the PNMA1 expression significantly increased in HNSCC and was associated with HNSCC patient's prognosis. Hence, PNMA1 could serve as a novel prognostic biomarker and a promising therapeutic target for HNSCC.http://www.sciencedirect.com/science/article/pii/S2212426823001343HealthMortalityCancerHead and neck cancerPrognosisNovel biomarker
spellingShingle Dakshitha Sankar
Balachander Kannan
Vijayashree Priyadharsini Jayaseelan
Jeevitha Manicka Vasagam
Paramasivam Arumugam
Alteration in PNMA1 expression is associated with poor prognosis and tumor immune infiltration in head and neck squamous cell carcinoma
Journal of Oral Biology and Craniofacial Research
Health
Mortality
Cancer
Head and neck cancer
Prognosis
Novel biomarker
title Alteration in PNMA1 expression is associated with poor prognosis and tumor immune infiltration in head and neck squamous cell carcinoma
title_full Alteration in PNMA1 expression is associated with poor prognosis and tumor immune infiltration in head and neck squamous cell carcinoma
title_fullStr Alteration in PNMA1 expression is associated with poor prognosis and tumor immune infiltration in head and neck squamous cell carcinoma
title_full_unstemmed Alteration in PNMA1 expression is associated with poor prognosis and tumor immune infiltration in head and neck squamous cell carcinoma
title_short Alteration in PNMA1 expression is associated with poor prognosis and tumor immune infiltration in head and neck squamous cell carcinoma
title_sort alteration in pnma1 expression is associated with poor prognosis and tumor immune infiltration in head and neck squamous cell carcinoma
topic Health
Mortality
Cancer
Head and neck cancer
Prognosis
Novel biomarker
url http://www.sciencedirect.com/science/article/pii/S2212426823001343
work_keys_str_mv AT dakshithasankar alterationinpnma1expressionisassociatedwithpoorprognosisandtumorimmuneinfiltrationinheadandnecksquamouscellcarcinoma
AT balachanderkannan alterationinpnma1expressionisassociatedwithpoorprognosisandtumorimmuneinfiltrationinheadandnecksquamouscellcarcinoma
AT vijayashreepriyadharsinijayaseelan alterationinpnma1expressionisassociatedwithpoorprognosisandtumorimmuneinfiltrationinheadandnecksquamouscellcarcinoma
AT jeevithamanickavasagam alterationinpnma1expressionisassociatedwithpoorprognosisandtumorimmuneinfiltrationinheadandnecksquamouscellcarcinoma
AT paramasivamarumugam alterationinpnma1expressionisassociatedwithpoorprognosisandtumorimmuneinfiltrationinheadandnecksquamouscellcarcinoma